Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT01367964
NA

Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

View on ClinicalTrials.gov

Summary

West syndrome (WS) is a specific type of epilepsy (or seizure disorder) that has three features: infantile spasms (type of seizure), loss of milestones, and a specific pattern on electroencephalogram (EEG or brain wave test) called hypsarhythmia. The purpose of this study is to detect pre-hypsarhythmia in infants at high-risk for WS and determine whether treatment with ACTH will prevent WS.

Official title: Early Treatment of Infants at High Risk of Developing West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)

Key Details

Gender

All

Age Range

2 Months - 12 Months

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2011-07

Completion Date

2020-05-05

Last Updated

2026-08-14

Healthy Volunteers

No

Conditions

Interventions

DRUG

adrenocorticotropin hormone

ACTH 16 units intramuscular injection once daily for 2 weeks

Locations (1)

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States